Hikma Pharmaceuticals PLC (‘Hikma’ or ‘Group’), the multinational pharmaceutical company, today reports its audited results for the year ended 31 December 2025. The Group reported revenue growth of 7% (6% in constant currency) to $3.349 billion, compared to $3.127 billion in 2024 with growth in all three geographies, North America, MENA, and Europe. Said Darwazah, […] The post Hikma delivers Group revenue and profit growth and announces share buyback and leadership changes appeared first on Web-Release.
Breaking News:
- Dubai Jewellery Group confirms during meeting with Dubai Chamber of Commerce that sector is operating at high capacity demonstrating resilience
- Geoffrey Alphonso, CEO of Alef Education, on Emirati Children’s Day
- Questions Raised Over Fairness and Context in Reporting by Nick McKenzie
- LG XD4 Dishwasher: More Than Clean – An Intelligent Upgrade for Ramadan Kitchens
- AtkinsRéalis Reports 39% Rise in Female Workforce Across GCC Operations
- H.E. Salama Al Ameemi: Safe Access to Digital Knowledge Strengthens Protection of Children in the UAE
- Statement by H.E. Dr. Ahmad Saeed bin Meshar Al Muhairi, SLC Secretary General, On Emirati Children’s Day 2026
- Ferrari today unveiled the Ferrari Amalfi Spider, a new 2+ spider from Maranello featuring a front-mid-mounted twin-turbo V8 engine.
Sunday, March 15